Blood lactate and lactate kinetics as treatment and prognosis markers for tissue hypoperfusion

Acta Clin Belg. 2020 Feb;75(1):1-8. doi: 10.1080/17843286.2018.1560612. Epub 2018 Dec 28.

Abstract

Objective: Blood lactate concentration (L) and lactate kinetic (LK) over time might be a helpful marker of the shock severity. The purpose of this study is to analyze whether the L and LK could correlate with the outcome and the therapy of patients with different types of shock.Methods: Design: A 3.5-year retrospective observational study. Patients: Eighteen years of age or older, diagnosed with shock were included. Arterial L measurements were performed upon admission and approximatively 3 and 6 h later. The evolution of lactate over this period of time was correlated with the outcome and therapy. Interventions: Univariate and multivariable statistical tests were performed to examine the relation between the initial L/LK and the in-hospital mortality, total mortality, length of stay (LOS), the LOS at the intensive care unit and the administered therapy. The optimal cut-off point of the LK over time to predict the mortality was calculated.Results: The initial L and the 6 h LK were significantly associated with the outcome. The higher the initial L and lower the LK, the higher the risk of mortality in the hospital or within 6 months. Moreover, the higher the initial L and lower the 6 h LK, the longer was the LOS. A relation between the initial L/LK and the required therapy was found. The optimal cut-off for the 6-h LK is 38.1%. Patients with a 6 h LK >38.1% had a significantly higher chance of survival.Conclusions: A significant relationship between the L/6-h LK and the outcome and treatment was found. The optimal survival cut-off point of 6 h LK in our study was 38.1%.

Keywords: Hypovolemic shock; cardiogenic shock; lactate kinetics; lactic acid; septic shock.

Publication types

  • Observational Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Biomarkers / metabolism
  • Female
  • Fluid Therapy / methods
  • Humans
  • Ischemia / blood*
  • Ischemia / metabolism
  • Ischemia / mortality
  • Ischemia / therapy
  • Lactic Acid / blood*
  • Lactic Acid / metabolism
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Prognosis
  • Respiration, Artificial
  • Retrospective Studies
  • Shock / blood*
  • Shock / metabolism
  • Shock / mortality
  • Shock / therapy
  • Time Factors
  • Vasoconstrictor Agents / therapeutic use
  • Young Adult

Substances

  • Biomarkers
  • Vasoconstrictor Agents
  • Lactic Acid